drugset / Trial / NCT00152451
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures
NaSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the efficacy and safety of ucb 44212 as add on therapy in subjects with focal epilepsy.
Timeline
- Start
- 2005-05-19
- Primary completion
- 2006-05-03
- Completion
- 2006-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seletracetam | Small molecule | 10 mg | Oral |
| Subject | Seletracetam | Small molecule | 20 mg | Oral |
| Subject | Seletracetam | Small molecule | 40 mg | Oral |
| Subject | Seletracetam | Small molecule | 80 mg | Oral |